OPKO Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on April 3, 2018. The report addresses a corporate governance event regarding the listing status of the company's common stock.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing event and contains no financial performance data.
Material Changes
On April 3, 2018, the Board of Directors resolved to voluntarily delist OPKO Health's common stock from The Tel Aviv Stock Exchange (TASE). Under applicable Israeli law, the delisting is expected to become effective three months from the date of the request. During this interim period, the stock will continue to trade on the TASE. All shares traded on the TASE are expected to transfer to The NASDAQ Global Market once the delisting becomes effective. The stock remains listed on NASDAQ.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the procedural details of the delisting. No unusual items or contingencies were reported in this document.
Key Facts for Investor Verification
- OPKO Health is voluntarily delisting from the Tel Aviv Stock Exchange (TASE).
- The delisting process is expected to take approximately three months to become effective.
- Shares currently trading on TASE will transfer to NASDAQ upon completion of the delisting.
- The company remains listed and trading on The NASDAQ Global Market.